Physician profile
Jamie E Carnell
NPI 1346632783
$479.12
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.66 · 2022: $167 · 2023: $71.58 · 2024: $116 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $121.67 | 2022 | |
| Janssen Biotech, INC. | $112.55 | 2025 | Talvey |
| Celgene Corporation | $96.00 | 2024 | Reblozyl |
| Novartis Pharmaceuticals Corporation | $51.26 | 2023 | |
| Seagen INC. | $26.22 | 2022 | |
| Daiichi Sankyo INC. | $20.32 | 2023 | Enhertu |
| Boston Scientific Corporation | $19.73 | 2024 | Spaceoar Vue System - 10ml |
| Alexion Pharmaceuticals, INC. | $18.71 | 2022 | |
| Pfizer INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Carnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.